Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaintel Regulatory News (MAI)

Share Price Information for Maintel (MAI)

Share Price is delayed by 15 minutes
Get Live Data
92.50    0.00 (0.00%)
Bid:
85.00
Ask:
100.00
Spread: 15.00 (17.647%)
Market Cap: £13.28m
MAI Live PriceLast checked at - London Stock Exchange

Intraday Maintel Share Chart

Acquisition

30 Sep 2011 07:00

RNS Number : 2482P
Maintel Holdings PLC
30 September 2011
 

 

 

Maintel Holdings Plc ("Maintel" or "the Company")

 

Acquisition

 

 

 

 

Maintel Holdings Plc, the telecoms and data services company, announces the acquisition, subject to shareholder approval, on 29 September 2011 of Totility Limited ("Totility"), a specialist UK mobile telecoms provider, for an initial consideration of £2.83m, with a further consideration of up to £4.0m dependent on Totility's performance in the 12 (in certain limited circumstances 13) months post-acquisition (the "Acquisition").

 

The initial consideration will consist of £2.44m in cash, and the issue of 177,778 shares, which had a mid-market price of 217.5p on 28 September. 

 

Further consideration will be paid to the Totility shareholders representing the net asset value of Totility at the date of Acquisition. Assets acquired will principally consist of working capital and recurring, renewal and new revenues arising from the customer bases managed under Totility's contracts with Vodafone and O2.

 

Totility manages approximately 1,100 customers and 12,000 mobile connections under these contracts, and reported unaudited revenues of £2.3m, gross profit of £1.4m and profit before tax of £1.0m for the year to 31 March 2011. Net assets as at 31 March 2011 were £557,000.

 

Terry McKeever, the managing director of Totility, will retain that position post-acquisition.

 

In addition to continued organic growth of Totility, the Company envisages significant cross-selling opportunities of its own services into Totility's customer base, as well as the sale of mobile services into its own base.

 

The Acquisition is conditional upon the Company entering into a loan agreement with John Booth, the Chairman of the Company, whereby Mr Booth would lend the Company up to £1.5m (the "Loan") to partially finance the Acquisition, and to allow the Company to maintain its ability to make other acquisitions of companies or bases as opportunities at appropriate valuations arise. The Loan is unsecured, carries an interest rate of 6.5 per cent. and is repayable by 28 February 2013.

 

In order to enter into the loan agreement, shareholders will be asked to approve a change to the Company's Articles to alter its ability to borrow, and a circular will be despatched to shareholders to that effect and will be available from the Company's website www.maintel.co.uk. The meeting to approve the change to the Articles will take place on 21 October 2011 and, assuming the proposal is approved, the Acquisition will complete that day.

 

The loan from John Booth, as described above, constitutes a related party transaction under the AIM Rules.

 

The Independent Directors, being Eddie Buxton, Angus McCaffrey, Dale Todd and Nicholas Taylor, who have been so advised by the Company's nominated adviser, finnCap Limited, believe that the terms of the Loan are fair and reasonable so far as the shareholders of the Company are concerned.

 

 

 

 

 

30 September 2011

 

 

Enquiries:

Maintel

Eddie Buxton - CEO 020 7401 4601

Angus McCaffery - Sales Director 020 7401 4646

Dale Todd - Finance Director 020 7401 0562

 

FinnCap

Marc Young - Corporate Finance 020 7600 1658

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUKSWRAKAKUAR
Date   Source Headline
17th Feb 20239:46 amRNSDirectorate Change
19th Jan 20233:33 pmRNSTrading Update
1st Nov 20227:00 amRNSBoard Update
29th Sep 20227:00 amRNSInterim Results
9th May 20224:15 pmRNSResult of AGM
5th May 20221:30 pmRNSGrant of Options
25th Apr 20223:55 pmRNSHolding(s) in Company
13th Apr 20224:30 pmRNSNotice of AGM
7th Apr 20227:00 amRNSAppointment of CFO
6th Apr 20227:00 amRNSGrant of Options
31st Mar 20227:00 amRNSFinal Results
25th Mar 20227:00 amRNSRefinancing Agreement with HSBC UK
18th Mar 20228:20 amRNSHolding(s) in Company
31st Jan 20227:30 amRNSTrading Update
28th Oct 202112:20 pmRNSHolding(s) in Company
25th Oct 20214:20 pmRNSHolding(s) in Company
1st Oct 20217:00 amRNSDirector Appointment
7th Sep 20217:00 amRNSInterim Results
3rd Sep 20214:37 pmRNSHolding(s) in Company
31st Aug 202112:30 pmRNSBoard Update and Notice of Results
30th Jun 20211:09 pmRNSResult of AGM//Board Change
2nd Jun 20212:06 pmRNSSecond Price Monitoring Extn
2nd Jun 20212:00 pmRNSPrice Monitoring Extension
2nd Jun 202111:05 amRNSSecond Price Monitoring Extn
2nd Jun 202111:00 amRNSPrice Monitoring Extension
2nd Jun 20219:05 amRNSSecond Price Monitoring Extn
2nd Jun 20219:00 amRNSPrice Monitoring Extension
2nd Jun 20217:00 amRNSBoard Changes
2nd Jun 20217:00 amRNSFinal Results
30th Apr 20214:10 pmRNSCompletion of Sale
18th Mar 20217:00 amRNSSale of Managed Print Services Business Unit
3rd Feb 20213:00 pmRNSGrant of Options
25th Jan 20217:00 amRNSTrading Update
22nd Jan 202112:49 pmRNSRule 2.8 Announcement
21st Jan 202111:00 amRNSPrice Monitoring Extension
11th Jan 20214:47 pmRNSHolding(s) in Company
11th Jan 20217:00 amRNSDirector Dealing
11th Dec 20204:19 pmRNSBoard Changes
25th Nov 20204:41 pmRNSSecond Price Monitoring Extn
25th Nov 20204:36 pmRNSPrice Monitoring Extension
25th Nov 20202:06 pmRNSSecond Price Monitoring Extn
25th Nov 20202:01 pmRNSPrice Monitoring Extension
18th Sep 20207:00 amRNSGrant & Exercise of Options & Total Voting Rights
15th Sep 20207:00 amRNSInterim Results
11th Sep 20209:00 amRNSDirector Appointment
3rd Sep 20204:49 pmRNSDirector/PDMR Shareholding
10th Aug 20207:00 amRNSDirector/PDMR Shareholding
6th Jul 20205:14 pmRNSDirector Dealings
1st Jul 20205:05 pmRNSDirector/PDMR Shareholding & Total Voting Rights
30th Jun 20204:28 pmRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.